| 奥氮平强化5-羟色胺再摄取抑制剂治疗难治性强迫症 |
| |
| 引用本文： | 林春湖,林怀洁.奥氮平强化5-羟色胺再摄取抑制剂治疗难治性强迫症[J].中国健康心理学杂志,2007,15(11):961-962. |
| |
| 作者姓名： | 林春湖 林怀洁 |
| |
| 作者单位： | 中国.广东汕头市第四人民医院角石住院部,515073;广东汕头市第二人民医院 |
| |
| 摘 要： | 目的 研究难治性强迫症用5-羟色胺再摄入抑制剂合用奥氮平强化治疗的疗效及安全性.方法 对难治性强迫症36例,采用Yale-Brown强迫量表,汉密顿焦虑量表(HAMA)及副反应量表(TESS)评定疗效和不良反应.结果 5-羟色胺再摄入抑制剂合用奥氮平治疗难治性强迫症疗效好.结论 5-羟色胺再摄入抑制剂合用奥氮平治疗难治性强迫症安全有效,值得推广.
|
| 关 键 词： | 难治性强迫症 奥氮平 5-羟色胺再摄取抑制剂 |
| 收稿时间： | 2007-03-14 |
| 修稿时间： | 2007年3月14日 |
A Study of Olanzapine and SRIs in the Treatment of Refractory Obsessive-Compulsive disorder (OCD) |
| |
| Lin Chunhu,Lin Huaijie.A Study of Olanzapine and SRIs in the Treatment of Refractory Obsessive-Compulsive disorder (OCD)[J].china journal of health psychology,2007,15(11):961-962. |
| |
| Authors: | Lin Chunhu Lin Huaijie |
| |
| Abstract: | Objective To study the efficacy and side effects of olanzapine and SRIs in the treatment of refractory obsessive-compulsive disorder(OCD). Methods 36 patients with refractory OCD were involved in this study, The efficacy was measured with Yale-Brown and Hamilton Anxiety Scale(HAMA). The side effects were determined by the Treatment Emergent Symptom Scale(TESS). Results Olanzapine and SRIs are effective drugs in the treatment of refractory OCD. Conclusion Olanzapine and SRIs in the treatment of refractory OCD are effective and safe. |
| |
| Keywords: | Refractory obsessive-compulsive disorder Olanzapine SRIs |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
